Showing results (51-60 of 292) with videos related to

Sort By:
Pageof 30
Applied Biochemistry and Biotechnology|March 13, 2008
A novel fully enzymatic method for determining glucose and 1,5-anhydro-D-glucitol in serum of one cuvetteFeng Jing, Lu Jun, Yuping Wang, et al.
World Journal of Gastrointestinal Oncology|December 5, 2019
Eight key long non-coding RNAs predict hepatitis virus positive hepatocellular carcinoma as prognostic targetsZi-Lin Huang, Wang Li, Qi-Feng Chen, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|September 13, 2005
[Imatinib mesylate STI571 therapy for five patients with advanced gastrointestinal stromal tumors]Kun-tang Shen, Ying-yong Hou, Xin-yu Qin, et al.
Frontiers in Oncology|April 9, 2026
Comparison of long-term prognoses between 3D-printed template-guided and conventional freehand interstitial brachytherapy for locally advanced cervical cancer: a single-center retrospective studyJun-Jun Miao, Xu-Yu Zhang, Yong-Xia Zhang, et al.
Oncology|September 12, 2008
Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarkerFeng Jing, Lu Jun, Zhang Yong, et al.
Translational Cancer Research|February 4, 2022
Clinical significance of IFIT2 expression in human renal cancer tissuesBin Xu, Yu-Lan Zhu, Jia-Lin Fan, et al.
World Journal of Gastroenterology|September 28, 2019
Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinomaQi-Feng Chen, Wang Li, Pei-Hong Wu, et al.
Zhonghua Yi Xue Za Zhi|September 14, 2013
[Metastatic characteristics of lymph node in supraclavicular zone and radiotherapy target volume for limited-stage small cell lung cancer]Zhen-xing Feng, Lu-jun Zhao, Yong Guan, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|April 30, 2015
[Construction and functional analysis of a bispecific antibody that targets TNF-α and ED-B]Lu-Jun Li, Yan-Qun Yang, Xue-Ping Hu, et al.
Frontiers in Immunology|November 27, 2025
Immune checkpoint inhibitors continuation beyond progression as second-line treatment for extensive-stage small-cell lung cancer: a real-world, multicenter analysisJiao Zhang, Rui Zi, Hai-Xia Zhang, et al.
Pageof 30